PharmaCyte Biotech (PMCB) Institutional Ownership $1.68 -0.04 (-2.33%) (As of 10:40 AM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for PharmaCyte Biotech (NASDAQ:PMCB)CurrentInstitutional OwnershipPercentage34.24%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$153.89KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$241.89K Get PMCB Insider Trade Alerts Want to know when executives and insiders are buying or selling PharmaCyte Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PMCB Institutional Buying and Selling by Quarter Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! PharmaCyte Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC168,200$321K0.0%-4.8%2.190% 11/15/2024 K2 Principal Fund L.P.209,266$400K0.1%-36.1%2.725% 5/14/2024 K2 Principal Fund L.P.327,503$776K0.1%+7.5%3.876% 2/14/2024 K2 Principal Fund L.P.304,613$655K0.1%+17.8%3.534% 11/15/2023 Sabby Management LLC97,124$204K0.1%N/A1.106% 11/13/2023 K2 Principal Fund L.P.258,481$543K0.1%+67.6%2.944% 10/17/2023Equitec Proprietary Markets LLC82,727$174K0.0%+34.7%0.942% 8/15/2023 K2 Principal Fund L.P.154,232$441K0.1%-78.7%1.757% 8/14/2023 CSS LLC IL13,186$38K0.0%N/A0.150% 7/12/2023Equitec Proprietary Markets LLC61,415$176K0.1%-81.4%0.366% 5/11/2023 K2 Principal Fund L.P.723,271$2.06M0.3%-1.2%4.146% 2/10/2023 K2 Principal Fund L.P.732,105$2.15M0.3%+19.8%3.909% 1/10/2023FNY Investment Advisers LLC31,100$90K0.1%N/A0.166% 10/26/2022 IQ EQ FUND MANAGEMENT IRELAND Ltd38,771$93K0.0%N/A0.187% 10/11/2022Equitec Proprietary Markets LLC330,694$794K0.2%-3.6%1.594% 10/4/2022 Csenge Advisory Group200,104$480K0.0%N/A0.964% 7/18/2022Equitec Proprietary Markets LLC342,994$768K0.2%+10.9%1.655% 5/17/2022 Shay Capital LLC944,666$2.17M0.3%+42.6%4.559% 4/25/2022FNY Investment Advisers LLC59,066$135K0.1%N/A0.285% 4/22/2022Equitec Proprietary Markets LLC309,294$711K0.2%+19.6%1.493% 2/15/2022 Shay Capital LLC662,337$1.66M0.3%+4,434.7%3.197% 1/31/2022Equitec Proprietary Markets LLC258,694$647K0.1%N/A1.249% 11/16/2021 Schonfeld Strategic Advisors LLC88,200$280K0.0%N/A0.426% 11/12/2021 NorthRock Partners LLC37,164$118K0.0%N/A0.179% (Data available from 1/1/2016 forward) PMCB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PMCB shares? During the previous two years, the following institutional investors and hedge funds held shares of PharmaCyte Biotech shares: K2 Principal Fund L.P. ($400K), Geode Capital Management LLC ($321K), Sabby Management LLC ($204K), Equitec Proprietary Markets LLC ($174K), and FNY Investment Advisers LLC ($90K), CSS LLC IL ($38K).Learn more on PMCB's institutional investors. What percentage of PharmaCyte Biotech stock is owned by institutional investors? 34.24% of PharmaCyte Biotech stock is owned by institutional investors. Learn more on PMCB's institutional investor holdings. Which institutional investors have been buying PharmaCyte Biotech stock? The following institutional investors have purchased PharmaCyte Biotech stock in the last 24 months: K2 Principal Fund L.P. ($294.21K), Sabby Management LLC ($97.12K), FNY Investment Advisers LLC ($31.10K), Equitec Proprietary Markets LLC ($21.31K), and CSS LLC IL ($13.19K). How much institutional buying is happening at PharmaCyte Biotech? Institutional investors have bought a total of 456,935 shares in the last 24 months. This purchase volume represents approximately $1.10M in transactions. Which PharmaCyte Biotech major shareholders have been selling company stock? The following institutional investors have sold PharmaCyte Biotech stock in the last 24 months: K2 Principal Fund L.P. ($696.11K), Equitec Proprietary Markets LLC ($269.28K), and Geode Capital Management LLC ($8.41K). How much institutional selling is happening at PharmaCyte Biotech? Institutional investors have sold a total of 973,794 shares in the last 24 months. This volume of shares sold represents approximately $2.67M in transactions. Related Companies CUE Institutional Ownership IOBT Institutional Ownership STTK Institutional Ownership IMMX Institutional Ownership DBVT Institutional Ownership TARA Institutional Ownership ACAB Institutional Ownership ITRM Institutional Ownership VTVT Institutional Ownership OCX Institutional Ownership This page (NASDAQ:PMCB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCyte Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmaCyte Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
